Carasent AB (CARA) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Karasent Q1 report for 2026. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to CEO Daniel Omen and CFO Svein-Martin Bjornstedt. Please go ahead. Good morning and welcome to our presentation of the first quarter of 2026. We will start with me giving a company update and then I will hand over to Sven Martin for more of a financial update. First, a quick overview of who we are. So our business is to help our customers who are private hospitals and clinics to help as many patients as possible. We do this through our EHR systems and related products. We're growing rapidly this quarter with 16% ARR growth and with highly recurring revenues. In this quarter, it's actually above 95%. And we have a net revenue retention of 111%. So looking a little bit more of the highlights of the first quarter. So as I mentioned, we had good ARR growth of 16%. And we continue to scale our business in a good way. In this quarter, we had almost 80% of the growth translating into profitability. And this is the way we've been working the last couple of years. And this is how we aim to continue working. In a quarter, we have quite low consulting revenues. And consulting revenues, they vary between quarters, very much depending on exactly what happens, which type of projects we have in each quarter. And what I think is also, and we also have mentioned many times before, consulting revenues are not our focus. That's not what we want to build our business on. And we're trying and we're working to move consulting revenues into ARR instead. It also makes it easier to convince the cust...